@technewslit@journa.host
@technewslit@journa.host avatar

technewslit

@technewslit@journa.host

#Reporter, #publisher, #photographer, #entrepreneur. CEO of digital publishing company Technology News and Literature. Photography chair, National Press Club. #BillsMafia #IowaHawkeyes

This profile is from a federated server and may be incomplete. Browse more on the original instance.

technewslit, to news
@technewslit@journa.host avatar

After 13 and a half years, the intersection of science and business remains a compelling subject, but there are other things I now want to do, and it's time to bring Science & Enterprise to a close.

https://sciencebusiness.technewslit.com/?p=45487

technewslit,
@technewslit@journa.host avatar

Thank you @meg ... That's very kind and much appreciated. Good luck to you as well.

technewslit,
@technewslit@journa.host avatar

@TinadeToetterbeck .... Happy Hanukkah Tina. Thanks for the kind words and support since G+ days. I'll keep posting here with photos and related projects. Enjoy your holidays.

technewslit, to news
@technewslit@journa.host avatar

The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration.

https://sciencebusiness.technewslit.com/?p=45483

#News #Press #Science #Business #Cancer #FDA #Biotechnology #PancreaticCancer #Tumor #Immunotherapy #FastTrack #ClinicalTrial #Nanoscale #Antibody #Australia

technewslit, to news
@technewslit@journa.host avatar

A developer of treatments for brain disorders and researchers at Stanford University aim to harness ultrasound to deliver drugs in nanoscale particles to precise regions of the brain.

https://sciencebusiness.technewslit.com/?p=45480

technewslit, to news
@technewslit@journa.host avatar

A developer of treatments for cancer and autoimmune disorders from stem cells says FDA cleared its request to start a clinical trial of its therapy for systemic lupus erythematosus.

https://sciencebusiness.technewslit.com/?p=45477

#News #Press #Science #Business #Lupus #SLE #Biotechnology #ClinicalTrial #Autoimmune #Cancer #FDA #ImmuneSystem #StemCells #Crispr #GeneEditing

technewslit, (edited ) to photography
@technewslit@journa.host avatar

Our exhibit of news photography from District of Columbia high schools is now live at National Press Club. The show runs through Friday.

Four schools taking part this time, with images of academics, athletics, and student life in general.

Exhibit catalog: https://technewslit.com/npc/dchsphoto/index.html

technewslit, to Biotechnology
@technewslit@journa.host avatar

A company developing DNA into a feasible method for large-scale data storage unveiled a credit card-sized device using DNA for off-line data storage.

https://sciencebusiness.technewslit.com/?p=45463

technewslit, to news
@technewslit@journa.host avatar

A collaboration between biotechnology and dairy products businesses seeks to identify peptides in milk to form into dietary supplements for people with mood disorders.

https://sciencebusiness.technewslit.com/?p=45460

#News #Press #Science #Business #Dairy #Milk #Peptides #AminoAcids #Biotechnology #Chemistry #MentalHealth #Anxiety #Depression #Collaboration
#DietarySupplements

technewslit, to news
@technewslit@journa.host avatar

A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures.

https://sciencebusiness.technewslit.com/?p=45455

technewslit, to news
@technewslit@journa.host avatar

A new challenge competition from XPrize calls for proactive and accessible health care solutions for improving the quality of life among older people worldwide.

https://sciencebusiness.technewslit.com/?p=45451

technewslit, to news
@technewslit@journa.host avatar

A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.

https://sciencebusiness.technewslit.com/?p=45448

#News #Press #Science #Business #Regulatory #ClinicalTrial #Biotechnology #UK #Germany #mRNA #Lungs #Respiratory #Inhaled #Lipid #Nanoparticles #Immune

technewslit, to news
@technewslit@journa.host avatar

A vaccine delivered with a patch device is shown in a clinical trial to generate neutralizing antibodies against measles and rubella similar to conventional injections.

https://sciencebusiness.technewslit.com/?p=45443

technewslit, (edited ) to news
@technewslit@journa.host avatar

According to CB Insights, venture investments in A.I. are declining each quarter in 2023, with the number of venture deals reaching a low level not seen since 2017.

https://sciencebusiness.technewslit.com/?p=45437

technewslit, to news
@technewslit@journa.host avatar

Researchers from university labs in the U.K. are developing models of brain cell interactions using a company's synthetic human cells derived from stem cells.

https://sciencebusiness.technewslit.com/?p=45434

technewslit, to news
@technewslit@journa.host avatar

A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding.

https://sciencebusiness.technewslit.com/?p=45429

#News #Press #Science #Business #Biotechnology #Tissue #Organs #Preclinical #StartUp #University #Engineering #Finance #VentureCapital #SeedFunds #ArtificialIntelligence #Robotics

technewslit, to random
@technewslit@journa.host avatar

Reuters describes the deal negotiations ... https://www.reuters.com/world/middle-east/secret-negotiations-that-led-gaza-hostages-deal-2023-11-22/

technewslit, to news
@technewslit@journa.host avatar

A challenge competition with a $50 million purse seeks new strategies to attack the global substance abuse epidemic, including personalized diagnostics and treatments.

https://sciencebusiness.technewslit.com/?p=45424

#News #Press #Science #Business #Alcohol #Opioids #Addiction #SubstanceAbuse #Relapse #Diagnostics #Treatment #Challenge #Competition #Biomarkers #MedicalDevice

w7voa, to random
@w7voa@journa.host avatar

Calling the drug fentanyl the number one killer of Americans between the ages of 18 and 45, President Biden today convened a White House meeting to examine every angle to try to further curb the flow of the deadly drug into the country. Details in my VOA radio report.

technewslit,
@technewslit@journa.host avatar

Thanks @w7voa ... Posted a few minutes ago ... https://sciencebusiness.technewslit.com/?p=45424

technewslit, to news
@technewslit@journa.host avatar

Data from three health repositories show a simple blood test reveals inherited and acquired genetic indicators, analyzed with artificial intelligence, to detect coronary heart disease.

https://sciencebusiness.technewslit.com/?p=45420

technewslit, to news
@technewslit@journa.host avatar

China and India provided more than half of all international students at U.S. universities in the last academic year, as total enrollment from overseas approached pre-pandemic levels.

https://sciencebusiness.technewslit.com/?p=45416

steventdennis, to random
@steventdennis@journa.host avatar

If you could ask any US senator a question, who would it be and what would you ask?

technewslit,
@technewslit@journa.host avatar

Thanks @steventdennis ... Two questions: (1) When will you kill the filibuster? and (2) When will you disclose all of your campaign funders?

samlitzinger, to random
@samlitzinger@journa.host avatar

I’m horrified by some of the things I see my neighbors posting on the NextDoor app.

“Does anyone know a bakery that makes strawberry pizza? I haven't been able to locate one.”

technewslit,
@technewslit@journa.host avatar

@samlitzinger ... I ditched that miserable excuse for an app months ago.

technewslit, to news
@technewslit@journa.host avatar

Health authorities in Sweden authorized the start of a clinical trial testing insulin-producing cells from donors engineered to prevent immune reactions in people with type 1 diabetes.

https://sciencebusiness.technewslit.com/?p=45412

technewslit, to news
@technewslit@journa.host avatar

Generate:Biomedicines describes its Chroma generative A.I. model in yesterday's issue of the journal Nature, and is making the model available as open source through GitHub.

https://sciencebusiness.technewslit.com/?p=45409

#News #Press #Science #Business #Protein #Therapeutics #ArtificialIntelligence #NeuralNetwork #GenerativeAI #OpenSource #DiffusionModel #University

  • All
  • Subscribed
  • Moderated
  • Favorites
  • •
  • JUstTest
  • kavyap
  • DreamBathrooms
  • thenastyranch
  • magazineikmin
  • tacticalgear
  • khanakhh
  • Youngstown
  • mdbf
  • slotface
  • rosin
  • everett
  • ngwrru68w68
  • Durango
  • megavids
  • InstantRegret
  • cubers
  • GTA5RPClips
  • cisconetworking
  • ethstaker
  • osvaldo12
  • modclub
  • normalnudes
  • provamag3
  • tester
  • anitta
  • Leos
  • lostlight
  • All magazines
    •